Role of complement on broken surfaces after trauma

Advances in Experimental Medicine and Biology

Volumn 865, Issue , 2015, Pages 43-55

  Huber Lang, Markus ^a   Ignatius, Anita ^a   Brenner, Rolf E ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Broken surfaces; Complement; Mesenchymal stem cells; Trauma

Indexed keywords

CELL PROTEIN; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; DAMAGE ASSOCIATED MOLECULAR PATTERN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; COMPLEMENT RECEPTOR;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE INJURY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONNECTIVE TISSUE; DISEASE PREDISPOSITION; FRACTURE HEALING; HEALING; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INTRAARTICULAR FRACTURE; MESENCHYMAL STEM CELL; MOLECULAR RECOGNITION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; POSTTRAUMATIC OSTEOARTHRITIS; PRIORITY JOURNAL; REPERFUSION INJURY; SOFT TISSUE INJURY; SYNOVIAL FLUID; CARTILAGE; FRACTURE; IMMUNOLOGY; INJURIES; INJURY SCALE; INNATE IMMUNITY; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

CARTILAGE; CHONDROCYTES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FRACTURES, BONE; HUMANS; IMMUNITY, INNATE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, COMPLEMENT; TRAUMA SEVERITY INDICES;

EID: 84940372595     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-18603-0_3     Document Type: Article

References (66)

1. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, Lambris JD, Warner RL, Flierl MA, Hoesel LM, Gebhard F, Younger JG, Drouin SM, Wetsel RA, Ward PA. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12:682-7.
2. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-7.
3. Zhao C, Itagaki K, Gupta A, Odom S, Sandler N, Hauser CJ. Mitochondrial damage-associated molecular patterns released by abdominal trauma suppress pulmonary immune responses. J Trauma Acute Care Surg. 2014;76:1222-7.
4. Brinkmann CR, Jensen L, Dagnaes-Hansen F, Holm IE, Endo Y, Fujita T, Thiel S, Jensenius JC, Degn SE. Mitochondria and the lectin pathway of complement. J Biol Chem. 2013;288:8016-27.
5. Huber-Lang M, Barratt-Due A, Pischke SE, Sandanger O, Nilsson PH, Nunn MA, Denk S, Gaus W, Espevik T, Mollnes TE. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice. J Immunol. 2014;192:5324-31.
6. Song WC. Crosstalk between complement and toll-like receptors. Toxicol Pathol. 2012;40:174-82.
7. Johansson PI, Windelov NA, Rasmussen LS, Sorensen AM, Ostrowski SR. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J Emerg Trauma Shock. 2013;6:171-5.
8. Burk AM, Martin M, Flierl MA, Rittirsch D, Helm M, Lampl L, Bruckner U, Stahl GL, Blom AM, Perl M, Gebhard F, Huber-Lang M. Early complementopathy after multiple injuries in humans. Shock. 2012;37:348-54.
9. Kanse SM, Gallenmueller A, Zeerleder S, Stephan F, Rannou O, Denk S, Etscheid M, Lochnit G, Krueger M, Huber-Lang M. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. J Immunol. 2012;188:2858-65.
10. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293-300.
11. Bohlson SS, O'Conner SD, Hulsebus HJ, Ho MM, Fraser DA. Complement, c1q, and c1qrelated molecules regulate macrophage polarization. Front Immunol. 2014;5:402.
12. Diepenhorst GM, van Gulik TM, Hack CE. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg. 2009;249:889-99.
13. Bless NM, Warner RL, Padgaonkar VA, Lentsch AB, Czermak BJ, Schmal H, Friedl HP, Ward PA. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am J Physiol. 1999;276:L57-63.
14. Duehrkop C, Banz Y, Spirig R, Miescher S, Nolte MW, Spycher M, Smith RA, Sacks SH, Rieben R. C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage. PLoS One. 2013;8, e72059.
15. Lindsay TF, Hill J, Ortiz F, Rudolph A, Valeri CR, Hechtman HB, Moore Jr FD. Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemiareperfusion. Ann Surg. 1992;216:677-83.
16. Woodruff TM, Arumugam TV, Shiels IA, Reid RC, Fairlie DP, Taylor SM. Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res. 2004;116:81-90.
17. Lotz MK, Kraus VB. New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther. 2010;12:211.
18. Brown TD, Johnston RC, Saltzman CL, Marsh JL, Buckwalter JA. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma. 2006;20:739-44.
19. Furman BD, Olson SA, Guilak F. The development of posttraumatic arthritis after articular fracture. J Orthop Trauma. 2006;20:719-25.
20. Brophy RH, Martinez M, Borrelli Jr J, Silva MJ. Effect of combined traumatic impact and radial transection of medial meniscus on knee articular cartilage in a rabbit in vivo model. Arthroscopy. 2012;28:1490-6.
21. McKinley TO, Borrelli Jr J, D'Lima DD, Furman BD, Giannoudis PV. Basic science of intraarticular fractures and posttraumatic osteoarthritis. J Orthop Trauma. 2010;24:567-70.
22. Honkonen SE. Degenerative arthritis after tibial plateau fractures. J Orthop Trauma. 1995;9:273-7.
23. Volpin G, Dowd GS, Stein H, Bentley G. Degenerative arthritis after intra-articular fractures of the knee. Long-term results. J Bone Joint Surg Br. 1990;72:634-8.
24. Jansen NW, Roosendaal G, Bijlsma JW, Degroot J, Lafeber FP. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum. 2007;56:199-207.
25. van Meegeren ME, Roosendaal G, Barten-van Rijbroek AD, Schutgens RE, Lafeber FP, Mastbergen SC. Coagulation aggravates blood-induced joint damage in dogs. Arthritis Rheum. 2012;64:3231-9.
26. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249-57.
27. Orlowsky EW, Kraus VB. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol. 2015;2(3):363-71.
28. Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014;289:35237-45.
29. Backus JD, Furman BD, Swimmer T, Kent CL, McNulty AL, Defrate LE, Guilak F, Olson SA. Cartilage viability and catabolism in the intact porcine knee following transarticular impact loading with and without articular fracture. J Orthop Res. 2011;29:501-10.
30. Lewis JL, Deloria LB, Oyen-Tiesma M, Thompson Jr RC, Ericson M, Oegema Jr TR. Cell death after cartilage impact occurs around matrix cracks. J Orthop Res. 2003;21:881-7.
31. Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009;30:83-90.
32. Heinegard D, Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol. 2011;7:50-6.
33. John T, Stahel PF, Morgan SJ, Schulze-Tanzil G. Impact of the complement cascade on posttraumatic cartilage inflammation and degradation. Histol Histopathol. 2007;22:781-90.
34. Bradley K, North J, Saunders D, Schwaeble W, Jeziorska M, Woolley DE, Whaley K. Synthesis of classical pathway complement components by chondrocytes. Immunology. 1996;88:648-56.
35. Schulze-Tanzil G, Kohl B, El SK, Arens S, Ertel W, Stolzel K, John T. Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines. Cell Tissue Res. 2012;350:465-75.
36. Onuma H, Masuko-Hongo K, Yuan G, Sakata M, Nakamura H, Kato T, Aoki H, Nishioka K. Expression of the anaphylatoxin receptor C5aR (CD88) by human articular chondrocytes. Rheumatol Int. 2002;22:52-5.
37. Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow MK, Holers VM, Lee DM, Robinson WH. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17:1674-9.
38. Happonen KE, Heinegard D, Saxne T, Blom AM. Interactions of the complement system with molecules of extracellular matrix: relevance for joint diseases. Immunobiology. 2012;217:1088-96.
39. Sjoberg AP, Manderson GA, Morgelin M, Day AJ, Heinegard D, Blom AM. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol. 2009;46:830-9.
40. Krumdieck R, Hook M, Rosenberg LC, Volanakis JE. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol. 1992;149:3695-701.
41. Bing DH, Almeda S, Isliker H, Lahav J, Hynes RO. Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci U S A. 1982;79:4198-201.
42. Almeda S, Rosenberg RD, Bing DH. The binding properties of human complement component C1q. Interaction with mucopolysaccharides. J Biol Chem. 1983;258:785-91.
43. Clark SJ, Bishop PN, Day AJ. The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation. Front Immunol. 2013;4:412.
44. Kalchishkova N, Furst CM, Heinegard D, Blom AM. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem. 2011;286:27915-26.
45. Melin FC, Morgelin M, Vadstrup K, Heinegard D, Aspberg A, Blom AM. The C-type lectin of the aggrecan G3 domain activates complement. PLoS One. 2013;8, e61407.
46. Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005;280:32301-8.
47. Happonen KE, Furst CM, Saxne T, Heinegard D, Blom AM. PRELP protein inhibits the formation of the complement membrane attack complex. J Biol Chem. 2012;287:8092-100.
48. Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom AM. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum. 2010;62:3574-83.
49. Acharya C, Yik JH, Kishore A, Van DV, Di Cesare PE, Haudenschild DR. Cartilage oligomeric matrix protein and its binding partners in the cartilage extracellular matrix: interaction, regulation and role in chondrogenesis. Matrix Biol. 2014;37:102-11.
50. Wang Y, Rollins SA, Madri JA, Matis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A. 1995;92:8955-9.
51. Okroj M, Heinegard D, Holmdahl R, Blom AM. Rheumatoid arthritis and the complement system. Ann Med. 2007;39:517-30.
52. Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Rheumatology (Oxford). 2007;46:1773-8.
53. Lepus CM, Song JJ, Wang Q, Wagner CA, Lindstrom TM, Chu CR, Sokolove J, Leung LL, Robinson WH. Brief report: carboxypeptidase B serves as a protective mediator in osteoarthritis. Arthritis Rheumatol. 2014;66:101-6.
54. Schmal H, Salzmann GM, Niemeyer P, Langenmair E, Guo R, Schneider C, Habel M, Riedemann N. Early intra-articular complement activation in ankle fractures. Biomed Res Int. 2014;2014:426893.
55. Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol. 2013;190:3839-47.
56. Huber-Lang M, Kovtun A, Ignatius A. The role of complement in trauma and fracture healing. Semin Immunol. 2013;25:73-8.
57. Recknagel S, Bindl R, Brochhausen C, Gockelmann M, Wehner T, Schoengraf P, Huber-Lang M, Claes L, Ignatius A. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. J Trauma Acute Care Surg. 2013;74:531-7.
58. Ignatius A, Schoengraf P, Kreja L, Liedert A, Recknagel S, Kandert S, Brenner RE, Schneider M, Lambris JD, Huber-Lang M. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1beta. J Cell Biochem. 2011;112:2594-605.
59. Hengartner NE, Fiedler J, Schrezenmeier H, Huber-Lang M, Brenner RE. Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma. PLoS One. 2015;10, e0116772.
60. Martel C, Cointe S, Maurice P, Matar S, Ghitescu M, Theroux P, Bonnefoy A. Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets. PLoS One. 2011;6, e18812.
61. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, Bruckner UB, Nilsson B, Gebhard F, Lambris JD, Huber-Lang M. Molecular intercommunication between the complement and coagulation systems. J Immunol. 2010;185:5628-36.
62. Huber-Lang M, Younkin EM, Sarma JV, Riedemann N, McGuire SR, Lu KT, Kunkel R, Younger JG, Zetoune FS, Ward PA. Generation of C5a by phagocytic cells. Am J Pathol. 2002;161:1849-59.
63. Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants -a review of the implications for the design of immunomodulatory biomaterials. Biomaterials. 2011;32:6692-709.
64. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. The role of complement in biomaterialinduced inflammation. Mol Immunol. 2007;44:82-94.
65. Noordin S, Shortkroff S, Sledge CB, Spector M. Investigation of the activation of a human serum complement protein, C3, by orthopedic prosthetic particulates. Biomaterials. 2004;25:5347-52.
66. DeHeer DH, Engels JA, DeVries AS, Knapp RH, Beebe JD. In situ complement activation by polyethylene wear debris. J Biomed Mater Res. 2001;54:12-9.